Stay updated with breaking news from T Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that high glucose impairs the antitumor activity of immune effector γδ-T cells, which contributes to the increased cancer risk in diabetes and that metabolic reprogramming by glucose control may improve the antitumor activity of γδ-T cells.
Researchers investigated whether severe COVID-19 patients exhibited inflammation and immune activation three months after hospitalization and explored the associations among COVID-19 severity, long COVID, and immune activation.
In a recent study, scientists reviewed the latest technological advancements and T cell epitope discovery associated with food allergy.
Promoted as "hill street" in a hospital. >> you gave your patients the wrong antibiotics. you don't know what medications they're on. you write the worst progress notes. you're pathetic. pathetic! >> bill? >> what? >> the doctor needs you right away. >> i'm sorry. >> "st. elsewhere" broke every rule there was and then built some new rules. >> the blood bank called a little while ago. they ran a routine panel on that pint of blood. t-cell count was off. >> they would have tragic things happen to these characters. there was real heartache in these people's lives and you really felt for them. >> ...